Ocotillo Dialysis (DVA) is a medicare approved dialysis facility center in Chandler, Arizona and it has 12 dialysis stations. It is located in Maricopa county at 975 W Chandler Heights Ste 101, Chandler, AZ, 85248. You can reach out to the office of Ocotillo Dialysis (DVA) at (480) 802-4405. This dialysis clinic is managed and/or owned by Davita. Ocotillo Dialysis (DVA) has the following ownership type - Profit. It was first certified by medicare in February, 2010. The medicare id for this facility is 032631 and it accepts patients under medicare ESRD program.
| Name | Ocotillo Dialysis (DVA) |
|---|---|
| Location | 975 W Chandler Heights Ste 101, Chandler, Arizona |
| No. of Dialysis Stations | 12 |
| Medicare ID | 032631 |
| Managed By | Davita |
| Ownership Type | Profit |
| Late Shifts | Yes |
| 975 W Chandler Heights Ste 101, Chandler, Arizona, 85248 | |
| (480) 802-4405 | |
News Archive
Over the past decade, mindfulness meditation has been shown to improve a broad range of health and disease outcomes, such as slowing HIV progression and improving healthy aging. Yet, little is known about the brain changes that produce these beneficial health effects.
Oculus Innovative Sciences, Inc., a commercial medical technology company that designs, produces and markets safe and effective tissue care products based upon the Microcyn® Technology platform, today unveiled Microcyn Solution with preservatives, at the New York Podiatric Clinical Conference & Exhibition being held in downtown Manhattan, January 29-31.
For consumers who are seeking insurance through the new law, the marketplace's technical problems have been frustrating, but many remain eager.
The Pharmaceutical Care Management Association (PCMA) issued the following statement on research cited by the Centers for Medicare & Medicaid Services (CMS) that found the most recent 10-year cost estimate for Medicare Part D came in at $373 billion, a 41 percent drop from the initial cost estimate of $634 billion for 2004-2013
› Verified 2 days ago
| NPI Number | 1770714701 |
| Organization Name | Ocotillo Dialysis |
| Doing Business As | Southwest Kidney Davita Dialysis Partners Llc |
| Address | 975 W Chandler Heights Rd Chandler, Arizona, 85248 |
| Phone Number | (480) 802-4405 |
News Archive
Over the past decade, mindfulness meditation has been shown to improve a broad range of health and disease outcomes, such as slowing HIV progression and improving healthy aging. Yet, little is known about the brain changes that produce these beneficial health effects.
Oculus Innovative Sciences, Inc., a commercial medical technology company that designs, produces and markets safe and effective tissue care products based upon the Microcyn® Technology platform, today unveiled Microcyn Solution with preservatives, at the New York Podiatric Clinical Conference & Exhibition being held in downtown Manhattan, January 29-31.
For consumers who are seeking insurance through the new law, the marketplace's technical problems have been frustrating, but many remain eager.
The Pharmaceutical Care Management Association (PCMA) issued the following statement on research cited by the Centers for Medicare & Medicaid Services (CMS) that found the most recent 10-year cost estimate for Medicare Part D came in at $373 billion, a 41 percent drop from the initial cost estimate of $634 billion for 2004-2013
› Verified 2 days ago
| Dialysis patients with Hemoglobin data | 32 |
| Medicare patients who had average hemoglobin (hgb) less than 10 g/dL | 6 |
News Archive
Over the past decade, mindfulness meditation has been shown to improve a broad range of health and disease outcomes, such as slowing HIV progression and improving healthy aging. Yet, little is known about the brain changes that produce these beneficial health effects.
Oculus Innovative Sciences, Inc., a commercial medical technology company that designs, produces and markets safe and effective tissue care products based upon the Microcyn® Technology platform, today unveiled Microcyn Solution with preservatives, at the New York Podiatric Clinical Conference & Exhibition being held in downtown Manhattan, January 29-31.
For consumers who are seeking insurance through the new law, the marketplace's technical problems have been frustrating, but many remain eager.
The Pharmaceutical Care Management Association (PCMA) issued the following statement on research cited by the Centers for Medicare & Medicaid Services (CMS) that found the most recent 10-year cost estimate for Medicare Part D came in at $373 billion, a 41 percent drop from the initial cost estimate of $634 billion for 2004-2013
› Verified 2 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
| Adult patients getting regular hemodialysis at the center | 75 |
| Adult patient months included in Kt/V greater than or equal to 1.2 | 599 |
| Percentage of adult patients getting regular hemodialysis at the center | 97 |
News Archive
Over the past decade, mindfulness meditation has been shown to improve a broad range of health and disease outcomes, such as slowing HIV progression and improving healthy aging. Yet, little is known about the brain changes that produce these beneficial health effects.
Oculus Innovative Sciences, Inc., a commercial medical technology company that designs, produces and markets safe and effective tissue care products based upon the Microcyn® Technology platform, today unveiled Microcyn Solution with preservatives, at the New York Podiatric Clinical Conference & Exhibition being held in downtown Manhattan, January 29-31.
For consumers who are seeking insurance through the new law, the marketplace's technical problems have been frustrating, but many remain eager.
The Pharmaceutical Care Management Association (PCMA) issued the following statement on research cited by the Centers for Medicare & Medicaid Services (CMS) that found the most recent 10-year cost estimate for Medicare Part D came in at $373 billion, a 41 percent drop from the initial cost estimate of $634 billion for 2004-2013
› Verified 2 days ago
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Ocotillo Dialysis (DVA) with elevated calcium levels.
| Patients with hypercalcemia | 79 |
| Hypercalcemia patient months | 632 |
| Patients with Serumphosphor | 80 |
| Patients with Serumphosphor less than 3.5 mg/dL | 12 |
| Patients with Serumphosphor from 3.5 to 4.5 mg/dL | 33 |
| Patients with Serumphosphor from 4.6 to 5.5 mg/dL | 32 |
| Patients with Serumphosphor from 5.6 to 7 mg/dL | 14 |
| Patients with Serumphosphor greater than 7 mg/dL | 9 |
News Archive
Over the past decade, mindfulness meditation has been shown to improve a broad range of health and disease outcomes, such as slowing HIV progression and improving healthy aging. Yet, little is known about the brain changes that produce these beneficial health effects.
Oculus Innovative Sciences, Inc., a commercial medical technology company that designs, produces and markets safe and effective tissue care products based upon the Microcyn® Technology platform, today unveiled Microcyn Solution with preservatives, at the New York Podiatric Clinical Conference & Exhibition being held in downtown Manhattan, January 29-31.
For consumers who are seeking insurance through the new law, the marketplace's technical problems have been frustrating, but many remain eager.
The Pharmaceutical Care Management Association (PCMA) issued the following statement on research cited by the Centers for Medicare & Medicaid Services (CMS) that found the most recent 10-year cost estimate for Medicare Part D came in at $373 billion, a 41 percent drop from the initial cost estimate of $634 billion for 2004-2013
› Verified 2 days ago
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
| Patients included in arterial venous fistula and catheter summaries | 71 |
| Patient months included in arterial venous fistula and catheter summaries | 418 |
| Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | 84 |
| Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer | 10 |
News Archive
Over the past decade, mindfulness meditation has been shown to improve a broad range of health and disease outcomes, such as slowing HIV progression and improving healthy aging. Yet, little is known about the brain changes that produce these beneficial health effects.
Oculus Innovative Sciences, Inc., a commercial medical technology company that designs, produces and markets safe and effective tissue care products based upon the Microcyn® Technology platform, today unveiled Microcyn Solution with preservatives, at the New York Podiatric Clinical Conference & Exhibition being held in downtown Manhattan, January 29-31.
For consumers who are seeking insurance through the new law, the marketplace's technical problems have been frustrating, but many remain eager.
The Pharmaceutical Care Management Association (PCMA) issued the following statement on research cited by the Centers for Medicare & Medicaid Services (CMS) that found the most recent 10-year cost estimate for Medicare Part D came in at $373 billion, a 41 percent drop from the initial cost estimate of $634 billion for 2004-2013
› Verified 2 days ago
The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.
| Standard Hospitalization Summary Ratio(SHR) Year | January, 2016 - December, 2016 |
| Patients in facility's Hospitalization Summary | 57 |
| Hospitalization Rate in facility | 209.3 (As Expected) |
| Hospitalization Rate: Upper Confidence Limit | 359.9 |
| Hospitalization Rate: Lower Confidence Limit | 126.4 |
News Archive
Over the past decade, mindfulness meditation has been shown to improve a broad range of health and disease outcomes, such as slowing HIV progression and improving healthy aging. Yet, little is known about the brain changes that produce these beneficial health effects.
Oculus Innovative Sciences, Inc., a commercial medical technology company that designs, produces and markets safe and effective tissue care products based upon the Microcyn® Technology platform, today unveiled Microcyn Solution with preservatives, at the New York Podiatric Clinical Conference & Exhibition being held in downtown Manhattan, January 29-31.
For consumers who are seeking insurance through the new law, the marketplace's technical problems have been frustrating, but many remain eager.
The Pharmaceutical Care Management Association (PCMA) issued the following statement on research cited by the Centers for Medicare & Medicaid Services (CMS) that found the most recent 10-year cost estimate for Medicare Part D came in at $373 billion, a 41 percent drop from the initial cost estimate of $634 billion for 2004-2013
› Verified 2 days ago
The rate of readmission show you whether patients who were being treated regularly at Ocotillo Dialysis (DVA) were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.
| Standard Readmission Summary Ratio(SRR) Year | January, 2016 - December, 2016 |
| Readmission Rate in facility | 29 (As Expected) |
| Readmission Rate: Upper Confidence Limit | 41.1 |
| Readmission Rate: Lower Confidence Limit | 18.9 |
News Archive
Over the past decade, mindfulness meditation has been shown to improve a broad range of health and disease outcomes, such as slowing HIV progression and improving healthy aging. Yet, little is known about the brain changes that produce these beneficial health effects.
Oculus Innovative Sciences, Inc., a commercial medical technology company that designs, produces and markets safe and effective tissue care products based upon the Microcyn® Technology platform, today unveiled Microcyn Solution with preservatives, at the New York Podiatric Clinical Conference & Exhibition being held in downtown Manhattan, January 29-31.
For consumers who are seeking insurance through the new law, the marketplace's technical problems have been frustrating, but many remain eager.
The Pharmaceutical Care Management Association (PCMA) issued the following statement on research cited by the Centers for Medicare & Medicaid Services (CMS) that found the most recent 10-year cost estimate for Medicare Part D came in at $373 billion, a 41 percent drop from the initial cost estimate of $634 billion for 2004-2013
› Verified 2 days ago
Hemodialysis treatment requires direct access to the bloodstream, which can be an opportunity for germs to enter the body and cause infection. This information shows how often patients at Ocotillo Dialysis (DVA) get infections in their blood each year compared to the number of infections expected for the center based on the national average.
| Standard Infection Summary Ratio(SIR) Year | January, 2016 - December, 2016 |
| Infection Rate in facility | .79 (As Expected) |
| SIR: Upper Confidence Limit | 2.15 |
| SIR: Lower Confidence Limit | .2 |
News Archive
Over the past decade, mindfulness meditation has been shown to improve a broad range of health and disease outcomes, such as slowing HIV progression and improving healthy aging. Yet, little is known about the brain changes that produce these beneficial health effects.
Oculus Innovative Sciences, Inc., a commercial medical technology company that designs, produces and markets safe and effective tissue care products based upon the Microcyn® Technology platform, today unveiled Microcyn Solution with preservatives, at the New York Podiatric Clinical Conference & Exhibition being held in downtown Manhattan, January 29-31.
For consumers who are seeking insurance through the new law, the marketplace's technical problems have been frustrating, but many remain eager.
The Pharmaceutical Care Management Association (PCMA) issued the following statement on research cited by the Centers for Medicare & Medicaid Services (CMS) that found the most recent 10-year cost estimate for Medicare Part D came in at $373 billion, a 41 percent drop from the initial cost estimate of $634 billion for 2004-2013
› Verified 2 days ago
Patients with anemia require blood transfusions if their anemia is not managed well by their dialysis center. This information shows whether Ocotillo Dialysis (DVA)'s rate of transfusions is better than expected, as expected, or worse than expected, compared to other centers that treat similar patients.
| Standard Transfusion Summary Ratio (STrR) Year | January, 2016 - December, 2016 |
| Patients in facility's Transfusion Summary | 48 |
| Transfusion Rate in facility | 31.9 (As Expected) |
| Transfusion Rate: Upper Confidence Limit | 111.4 |
| Transfusion Rate: Lower Confidence Limit | 10.7 |
News Archive
Over the past decade, mindfulness meditation has been shown to improve a broad range of health and disease outcomes, such as slowing HIV progression and improving healthy aging. Yet, little is known about the brain changes that produce these beneficial health effects.
Oculus Innovative Sciences, Inc., a commercial medical technology company that designs, produces and markets safe and effective tissue care products based upon the Microcyn® Technology platform, today unveiled Microcyn Solution with preservatives, at the New York Podiatric Clinical Conference & Exhibition being held in downtown Manhattan, January 29-31.
For consumers who are seeking insurance through the new law, the marketplace's technical problems have been frustrating, but many remain eager.
The Pharmaceutical Care Management Association (PCMA) issued the following statement on research cited by the Centers for Medicare & Medicaid Services (CMS) that found the most recent 10-year cost estimate for Medicare Part D came in at $373 billion, a 41 percent drop from the initial cost estimate of $634 billion for 2004-2013
› Verified 2 days ago
The rate of mortality show you whether patients who were being treated regularly at Ocotillo Dialysis (DVA) lived longer than expected (better than expected), don’t live as long as expected (worse than expected), or lived as long as expected (as expected), compared to similar patients treated at other facilities.
| Standard Survival Summary Ratio(SIR) Year | January, 2013 - December, 2016 |
| Patients in facility's Survival Summary | 281 |
| Mortality Rate in facility | 20.4 (As Expected) |
| Mortality Rate: Upper Confidence Limit | 27.5 |
| Mortality Rate: Lower Confidence Limit | 14.8 |
News Archive
Over the past decade, mindfulness meditation has been shown to improve a broad range of health and disease outcomes, such as slowing HIV progression and improving healthy aging. Yet, little is known about the brain changes that produce these beneficial health effects.
Oculus Innovative Sciences, Inc., a commercial medical technology company that designs, produces and markets safe and effective tissue care products based upon the Microcyn® Technology platform, today unveiled Microcyn Solution with preservatives, at the New York Podiatric Clinical Conference & Exhibition being held in downtown Manhattan, January 29-31.
For consumers who are seeking insurance through the new law, the marketplace's technical problems have been frustrating, but many remain eager.
The Pharmaceutical Care Management Association (PCMA) issued the following statement on research cited by the Centers for Medicare & Medicaid Services (CMS) that found the most recent 10-year cost estimate for Medicare Part D came in at $373 billion, a 41 percent drop from the initial cost estimate of $634 billion for 2004-2013
› Verified 2 days ago
Chandler Dialysis (FMC) Location: 912 W Chandler Blvd Bldg A-d, Chandler, Arizona, 85225 Phone: (480) 821-9801 |
Ocotillo Dialysis (DVA) Location: 975 W Chandler Heights Ste 101, Chandler, Arizona, 85248 Phone: (480) 802-4405 |
News Archive
Over the past decade, mindfulness meditation has been shown to improve a broad range of health and disease outcomes, such as slowing HIV progression and improving healthy aging. Yet, little is known about the brain changes that produce these beneficial health effects.
Oculus Innovative Sciences, Inc., a commercial medical technology company that designs, produces and markets safe and effective tissue care products based upon the Microcyn® Technology platform, today unveiled Microcyn Solution with preservatives, at the New York Podiatric Clinical Conference & Exhibition being held in downtown Manhattan, January 29-31.
For consumers who are seeking insurance through the new law, the marketplace's technical problems have been frustrating, but many remain eager.
The Pharmaceutical Care Management Association (PCMA) issued the following statement on research cited by the Centers for Medicare & Medicaid Services (CMS) that found the most recent 10-year cost estimate for Medicare Part D came in at $373 billion, a 41 percent drop from the initial cost estimate of $634 billion for 2004-2013
› Verified 2 days ago